Addus HomeCare Corporation (NASDAQ:ADUS) Given Consensus Recommendation of “Moderate Buy” by Analysts

Shares of Addus HomeCare Corporation (NASDAQ:ADUS) have received an average recommendation of “Moderate Buy” from the eleven research firms that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, seven have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $134.3333.

ADUS has been the subject of several research reports. KeyCorp restated an “overweight” rating on shares of Addus HomeCare in a research report on Wednesday. Barclays dropped their target price on shares of Addus HomeCare from $117.00 to $112.00 and set an “underweight” rating on the stock in a research note on Tuesday, February 24th. Wall Street Zen upgraded shares of Addus HomeCare from a “buy” rating to a “strong-buy” rating in a research note on Monday, February 23rd. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Addus HomeCare in a report on Wednesday, January 21st. Finally, Truist Financial set a $135.00 price objective on Addus HomeCare and gave the company a “buy” rating in a research note on Wednesday, January 7th.

Insider Activity

In other Addus HomeCare news, EVP David W. Tucker sold 704 shares of the company’s stock in a transaction dated Tuesday, February 24th. The shares were sold at an average price of $107.35, for a total transaction of $75,574.40. Following the sale, the executive vice president directly owned 10,802 shares of the company’s stock, valued at $1,159,594.70. This represents a 6.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO R Dirk Allison sold 4,988 shares of the stock in a transaction dated Tuesday, February 24th. The stock was sold at an average price of $106.98, for a total transaction of $533,616.24. Following the transaction, the chief executive officer owned 185,514 shares of the company’s stock, valued at $19,846,287.72. This represents a 2.62% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 16,926 shares of company stock worth $1,804,969. 4.50% of the stock is owned by company insiders.

Institutional Trading of Addus HomeCare

A number of institutional investors have recently modified their holdings of ADUS. Capital Research Global Investors boosted its holdings in Addus HomeCare by 22.3% in the 4th quarter. Capital Research Global Investors now owns 1,469,752 shares of the company’s stock worth $157,837,000 after buying an additional 268,192 shares during the period. Vanguard Group Inc. boosted its holdings in shares of Addus HomeCare by 0.8% in the fourth quarter. Vanguard Group Inc. now owns 1,308,605 shares of the company’s stock worth $140,531,000 after acquiring an additional 10,501 shares during the period. Wasatch Advisors LP grew its position in shares of Addus HomeCare by 0.8% in the third quarter. Wasatch Advisors LP now owns 936,243 shares of the company’s stock valued at $110,467,000 after purchasing an additional 7,089 shares in the last quarter. State Street Corp raised its stake in shares of Addus HomeCare by 0.9% during the 4th quarter. State Street Corp now owns 702,229 shares of the company’s stock valued at $75,412,000 after purchasing an additional 6,561 shares during the period. Finally, Dimensional Fund Advisors LP raised its stake in shares of Addus HomeCare by 1.2% during the 3rd quarter. Dimensional Fund Advisors LP now owns 667,256 shares of the company’s stock valued at $78,729,000 after purchasing an additional 7,884 shares during the period. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

More Addus HomeCare News

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Large institutional holders have been adding to positions in recent quarters, which provides a steady shareholder base and underlying demand. MarketBeat ADUS Institutional Holdings
• Positive Sentiment: Stephens kept an “Overweight” rating on ADUS and a $135 price target (trimmed from $140), signaling continued analyst conviction even after the cut. That backing can limit downside over the medium term. Stephens PT story
• Neutral Sentiment: Short‑interest figures are inconsistent across feeds (some reports show zero or NaN, others show a material rise). This data noise makes it hard to interpret immediate short pressure — confirm with FINRA/exchange data before acting. MarketBeat short interest
• Negative Sentiment: Significant insider selling across Feb. 24–25: CEO R. Dirk Allison and multiple EVPs sold several thousand shares in aggregate (CEO filings disclosed to the SEC). Large, concentrated insider sales are weighing on sentiment and likely contributed to today’s weakness. CEO SEC filing
• Negative Sentiment: Media flagged a “pessimistic forecast” narrative after Stephens trimmed its target, which can reinforce short‑term selling despite the retained Overweight rating. That coverage likely amplified intra‑day pressure. AmericanBankingNews piece
• Negative Sentiment: Smaller insider sales (e.g., EVP Cliff Blessing) were also reported; while individually minor, the wave of coordinated filings increases headline risk and may trigger mechanical selling. InsiderTrades alert

Addus HomeCare Stock Performance

Shares of Addus HomeCare stock opened at $103.53 on Monday. The business’s fifty day simple moving average is $109.22 and its 200 day simple moving average is $112.93. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.11. Addus HomeCare has a 12 month low of $88.96 and a 12 month high of $124.43. The firm has a market capitalization of $1.92 billion, a P/E ratio of 19.87, a price-to-earnings-growth ratio of 1.44 and a beta of 0.92.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.